Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001354488-16-007803
Filing Date
2016-06-13
Accepted
2016-06-13 16:35:15
Documents
1
Period of Report
2016-06-15
Effectiveness Date
2016-06-13

Document Format Files

Seq Description Document Type Size
1 INFORMATION STATEMENT sbfm_def14c.htm DEF 14C 90090
  Complete submission text file 0001354488-16-007803.txt   91399
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-52898 | Film No.: 161711084
SIC: 8731 Services-Commercial Physical & Biological Research